William Blair Reaffirms “Outperform” Rating for Encompass Health (NYSE:EHC)

William Blair restated their outperform rating on shares of Encompass Health (NYSE:EHC) in a research note released on Friday morning,RTT News reports. William Blair also issued estimates for Encompass Health’s Q1 2025 earnings at $1.16 EPS, Q2 2025 earnings at $1.12 EPS, Q3 2025 earnings at $1.14 EPS, Q4 2025 earnings at $1.32 EPS and FY2026 earnings at $5.39 EPS.

Several other equities analysts have also issued reports on the company. Truist Financial restated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays upped their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $107.33.

Encompass Health Trading Up 1.3 %

Shares of EHC stock opened at $99.86 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business’s 50 day moving average is $96.28 and its two-hundred day moving average is $95.19. The company has a market cap of $10.06 billion, a PE ratio of 22.39, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. Encompass Health has a 12 month low of $72.37 and a 12 month high of $104.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Equities analysts predict that Encompass Health will post 4.76 EPS for the current year.

Institutional Investors Weigh In On Encompass Health

Several large investors have recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares during the period. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares in the last quarter. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health in the third quarter worth $40,000. Finally, Tompkins Financial Corp bought a new position in Encompass Health in the fourth quarter valued at $46,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.